A PHASE 1 RANDOMIZED, CONTROLLED, OBSERVER-BLINDED, MULTICENTER STUDY TO EVALUATE SAFETY, TOLERABILITY AND IMMUNOGENICITY OF AN INVESTIGATIONAL ADJUVANTED TETANUS/DIPHTHERIA/PERTUSSIS BOOSTER VACCINE (TDAP-1018) IN ACELLULAR PERTUSSIS VACCINE PRIMED HEALTHY VOLUNTEERS 18 TO 23 YEARS OF AGE
- Registry ID
- DV2-TDAP-02
- Source registry
- HEALTH_CANADA
- Status
- Pending
- Phase
- PHASE1
- Study type
- INTERVENTIONAL
- Sponsor
- DYNAVAX TECHNOLOGIES CORPORATION
- Last update
- 2022-07-29
Conditions
- TETANUS
- PERTUSSIS
- DIPHTHERIA
View on source registry